These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 9375948)

  • 1. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?
    Hjalmarson A
    Basic Res Cardiol; 2000; 95 Suppl 1():I41-5. PubMed ID: 11192352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial data on the cardioprotective effects of beta-blockade.
    Kendall MJ
    Basic Res Cardiol; 2000; 95 Suppl 1():I25-30. PubMed ID: 11192348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers and amiodarone for the primary prevention of sudden cardiac death.
    Frankenberger O; Steinberg JS
    Curr Cardiol Rep; 1999 Nov; 1(4):274-81. PubMed ID: 10980854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfarction use of beta-blockers in elderly patients.
    Aronow WS
    Drugs Aging; 1997 Dec; 11(6):424-32. PubMed ID: 9413700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric therapy with beta-blockers.
    Hjalmarson A
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
    Adamson PB; Vanoli E; Shibano T; Foreman RD; Schwartz PJ
    J Cardiovasc Pharmacol; 2003 May; 41(5):665-70. PubMed ID: 12717095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When is drug therapy warranted to prevent sudden cardiac death?
    Singh BN
    Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.